Watch CLOV. Know when insiders buy.
One email the day a filing lands. Free.
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
4.34
+0.05 +1.17%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
70
PASS · shorts 70
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $2.5B +54.0%NET INCOME −$18.4MNET CASH $58.3M52W 1.70 – 5.41SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $743.2M | +55.6% | — | $28M | $28M | — | 0.05 | $25.2M | $682K | $24.5M | Aug 7 |
| Q1 2026 · Mar 31 | $749.2M | +62.0% | — | $27.3M | $27.3M | — | 0.05 | $107.9M | $854K | $107M | Aug 7 |
| Q4 2025 · Dec 31derived | $487.7M | +44.7% | — | −$49.3M | −$49.3M | — | — | −$68.2M | $597K | −$68.7M | Feb 27 |
| Q3 2025 · Sep 30 | $496.6M | +50.1% | — | −$24.4M | −$24.4M | — | — | $12.1M | $692K | $11.4M | Nov 7 |
| Q2 2025 · Jun 30 | $477.6M | +34.1% | — | −$10.6M | −$10.6M | −242.8% | -0.02 | $5.4M | $569K | $4.8M | Aug 7 |
| Q1 2025 · Mar 31 | $462.3M | +33.3% | — | −$1.3M | −$1.3M | — | 0.00 | −$16.3M | $185K | −$16.5M | Aug 7 |
| Q4 2024 · Dec 31derived | $337M | +7.9% | — | −$21.4M | −$22.1M | — | — | −$85.8M | $315K | −$86.1M | Feb 27 |
| Q3 2024 · Sep 30 | $331M | +8.2% | 24.5% | −$8.8M | −$9.2M | — | — | $50M | $399K | $49.6M | Nov 7 |
| Q2 2024 · Jun 30 | $356.3M | — | 30.3% | $7.2M | $7.4M | — | — | $44.8M | $397K | $44.4M | Nov 7 |
| Q1 2024 · Mar 31 | $346.9M | — | 23.6% | −$22.7M | −$19.2M | — | — | $25.9M | $445K | $25.5M | Nov 7 |
| Q4 2023 · Dec 31derived | $312.4M | — | 20.5% | −$63.1M | −$70.5M | — | -0.14 | −$258.1M | −$264K | −$257.8M | Feb 27 |
| Q3 2023 · Sep 30 | $306M | — | 23.0% | −$33.6M | −$41.5M | — | -0.09 | −$18.8M | $243K | −$19M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.9B | — | −$85.5M | −$85.5M | -4.4% | — | −$66.9M | $2M | −$69M | $18.3M | — |
| FY2024 · to Dec 31 | $1.4B | — | −$45.7M | −$43M | -3.1% | — | $34.8M | $1.6M | $33.3M | $1.8M | — |
| FY2023 · to Dec 31 | $1.3B | 20.4% | −$205.3M | −$213.4M | -16.9% | -0.44 | −$144.7M | $584K | −$145.2M | $0 | — |
| FY2022 · to Dec 31 | $1.1B | 6.4% | −$286.7M | −$339.6M | -31.0% | -0.71 | −$203.9M | $4.5M | −$208.4M | $0 | — |
| FY2021 · to Dec 31 | $1.5B | -5.4% | −$637M | −$587.8M | -39.9% | -1.42 | −$282.3M | $723K | −$283M | $147K | — |
| FY2020 · to Dec 31 | $672.9M | — | −$92.7M | −$136.4M | -20.3% | -1.54 | −$118.5M | $693K | −$119.2M | $0 | — |
Every number comes from CLOVER HEALTH INVESTMENTS, CORP. /DE's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.